Phase2Phase Biopharma Overview
- Investor Type
-
Venture Capital
- Status
-
Active
- Professionals
-
2
- Investments
-
14
- Portfolio
-
10
- Exits
-
3
Phase2Phase Biopharma General Information
Company Description
Founded in 2017, Phase2Phase Biopharma is a venture capital firm based in Stockholm, Sweden. The firm seeks to invest in early-stage life science startups.
Business Details
Website
phase2phase.comYear Founded
Investor Status
Primary Investor Type
Corporate Office
- Nanna Svartz väg 4
- 171 65 Solna
- Sweden
Phase2Phase Biopharma Investments (14)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| AAX Biotech | 02-Oct-2024 | Early Stage VC | Discovery Tools (Healthcare) | Generating Revenue | ||
| AAX Biotech | 28-Jun-2023 | Discovery Tools (Healthcare) | Generating Revenue | |||
| Key2brain | 01-May-2023 | Drug Discovery | Clinical Trials - General | |||
| Neogap | 01-May-2023 | Drug Discovery | Clinical Trials - Phase 2 | |||
| Synartro | 01-May-2023 | Drug Discovery | Pre-Clinical Trials | |||
| Vakona | 29-Mar-2023 | Biotechnology | Clinical Trials - Phase 1 | |||
| Akiram Therapeutics | 12-Jan-2023 | Drug Discovery | Clinical Trials - Phase 1 | |||
| PharmNovo | 03-Jun-2022 | Drug Discovery | Clinical Trials - Phase 2 | |||
| Vakona | 09-Nov-2021 | Early Stage VC | Biotechnology | Clinical Trials - Phase 1 | ||
| Genagon Therapeutics | 25-Mar-2021 | Later Stage VC | Drug Discovery | Out of Business |
Phase2Phase Biopharma Exits (3)
| Company Name | Exit Date | Exit Type | Exit Size |
|---|---|---|---|
| Genagon Therapeutics | 23-Dec-2023 | Out of Business | |
| Athera Biotechnologies | 01-Nov-2022 |
Phase2Phase Biopharma Investments by Industry, Year, and Region
Phase2Phase Biopharma Co-Investors (15)
| Name | With | Exits | Lead Partner | Series | Industry |
|---|---|---|---|---|---|
| Northislet | 3 |
|
|
||
| Sciety |
|
|
|||
| Jinderman & Partners |
|
|
|||
| Life Science Invest |
|
|
|||
| Linc (Sweden) |
|
|
Phase2Phase Biopharma FAQs
-
What is Phase2Phase Biopharma?
Founded in 2017, Phase2Phase Biopharma is a venture capital firm based in Stockholm, Sweden.
-
When was Phase2Phase Biopharma founded?
Phase2Phase Biopharma was founded in 2017.
-
Where is Phase2Phase Biopharma headquartered?
Phase2Phase Biopharma is headquartered in Solna, Sweden.
-
How many investments has Phase2Phase Biopharma made?
Phase2Phase Biopharma has made 14 investments.
-
What has Phase2Phase Biopharma invested in?
Phase2Phase Biopharma has made numerous investments in companies like AAX Biotech, Key2brain, and Neogap within the Discovery Tools (Healthcare) and Drug Discovery industries.
-
What has Phase2Phase Biopharma invested in recently?
Phase2Phase Biopharma's latest investment was on 02-Oct-2024 in AAX Biotech, a company within the Discovery Tools (Healthcare) industry.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process